[artículo] 
inJournal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 556-559

Título :	Pindolol augmentation in patients with treatment-resistant panic disorder: a double-blind, placebo-controlled trial
Tipo de documento:	texto impreso
Autores:	Shmuel Hirschmann, Autor ; Pinhas N. Dannon, Autor ; Iulian Iancu, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 556-559
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Ansiolíticos, Farmacoterapia, Fluvoxamina, Trastorno de pánico, Pindolol.
Resumen:	The objective of this study was to determine the efficacy of pindolol as an augmentor of fluoxetine in treatment-resistant panic disorder (PD). Twenty-five outpatients having PD with or without agoraphobia were included. These patients had not responded to two different trials with antidepressants and an 8-week trial of fluoxetine 20 mg/day.
Link:	./index.php?lvl=notice_display&id=31171

[artículo] Pindolol augmentation in patients with treatment-resistant panic disorder: a double-blind, placebo-controlled trial [texto impreso] / Shmuel Hirschmann, Autor ; Pinhas N. Dannon, Autor ; Iulian Iancu, Autor . - 2023 . - pp. 556-559.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 556-559

Palabras clave:	Ansiolíticos, Farmacoterapia, Fluvoxamina, Trastorno de pánico, Pindolol.
Resumen:	The objective of this study was to determine the efficacy of pindolol as an augmentor of fluoxetine in treatment-resistant panic disorder (PD). Twenty-five outpatients having PD with or without agoraphobia were included. These patients had not responded to two different trials with antidepressants and an 8-week trial of fluoxetine 20 mg/day.
Link:	./index.php?lvl=notice_display&id=31171